Insider Purchases: Inside the Buy
Tag: value stocks
Insiders Had Bought Shares of Elanco Animal Health (ELAN); Turns Out They Were Right — And It May Only Be the Beginning!
Insiders bought millions of Elanco shares under $15 — and they were right. Now, with JP Morgan’s upgrade and revenues rising, this stock might be a hidden gem in the animal health world. 🐾
CEO, CFO, COO, and President, CooperVision, Are All Buying Shares of The Cooper Companies. Should You?
The CEO, CFO, COO, and President of CooperCompanies all just bought shares. Insiders, institutions, and even the company itself are betting on the stock. Value play or just another lens cleaner? 👓💸
Western Union (WU): Cash Transfers, CEO Buys, and Maybe a Stock Rebound?
💸 Western Union’s CEO and CFO just wired big money into their own stock. Institutions already hold 95% of the float, but growth is flat, competition is fierce, and risks abound. Is this a bargain play — or a value trap in disguise?
Can Olin Cock Its Stock? Insiders Say Yes (Lock, Load, and Maybe Profit)
Olin ($OLN) insiders are loading up on shares while institutions already own 94% of the float. Profits are weak, ammo is hot, and bleach is… bleach. Can this 132-year-old company cock its stock for a rebound?
Not Everybody Likes Hunting, But Insiders Preyed On Sportsman's Warehouse's Stock
Sportsman's Warehouse (SPWH) may be wounded, but insiders are on the prowl. With CEO and directors buying stock, and a valuation that screams “cheap,” is this outdoor retailer staging a comeback? Time to load up—or duck?
Magnera: Insiders Keep Buying… Should You?
Magnera’s boardroom is buying diapers—literally. With insiders piling in and free cash flow returning, this specialty materials firm might be worth more than just its wipes. But don’t forget the debt and diaper jokes.
Can Tidewater Become a Tsunami? Insider Says Yes!
Director Robotti keeps loading up on Tidewater stock—and he’s not alone. With over 100% institutional ownership, strong free cash flow, and improving margins, TDW may be ready to roar. Is a tsunami coming? Funanc1al dives in.
This Wound Care Stock Doesn't Have to Hurt! 🩸🩼
CEO Joseph Capper is buying big. The company’s 9% full-year sales growth and 20%+ EBITDA margins suggest something’s brewing at this placental powerhouse. From PURION™ to profitability—this is wound care with a serious upside.
💼 The Godman Sachs Group, Inc. (GS): Where Wall Street Power Lunches with Olympus 🍽️📈
With soaring Q1 profits, billions returned to shareholders, and insiders buying in, Goldman Sachs is flexing its Wall Street muscle. From record M&A rankings to a $40B buyback plan, find out why GS might be the most solid financial play in your portfolio (and possibly Olympus). ⚖️💰
💵 Dollar Tree (DLTR): Where the Discounts Are Deep and the Insiders Dig In 🛒💰
Dollar Tree (DLTR) is proving there’s value in the value aisle. With insiders scooping up shares and Wall Street’s biggest names buying in, this discount retailer is making some noise. Add steady growth, a clever new pricing strategy, and a solid valuation, and you’ve got a stock that just might surprise you. 🛒💰